Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma.
Journal: Blood
Published: October 15, 2024
Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.
Journal: Blood advances
Published: September 30, 2024
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development.
Journal: Journal of autoimmunity
Published: June 26, 2020
Showing 1-3 of 3
Last Updated: 09/26/2026